SEC Comment Letter 0000000000-25-001162 to Onconetix, Inc. (ONCO)

Onconetix, Inc.
Date: Feb. 3, 2025 · CIK: 0001782107 · Accession: 0000000000-25-001162

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-284507

Date

February 3, 2025

Author

Karina Fedasz

Form

UPLOAD

Company

Onconetix, Inc.

Letter

February 3, 2025 Karina Fedasz Interim Chief Financial Officer Onconetix, Inc. 201 E. Fifth Street, Suite 1900 Cincinnati, OH 45202 Re:Onconetix, Inc. Registration Statement on Form S-1 Filed January 27, 2025 File No. 333-284507 Dear Karina Fedasz: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jessica Yuan, Esq.

Show Raw Text

February 3, 2025
Karina Fedasz
Interim Chief Financial Officer
Onconetix, Inc.
201 E. Fifth Street, Suite 1900
Cincinnati, OH 45202
Re:Onconetix, Inc.
Registration Statement on Form S-1
Filed January 27, 2025
File No. 333-284507
Dear Karina Fedasz:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jessica Yuan, Esq.

SecProbe.io